08.11.26 -- How Exit Strategy Should Shape Clinical Trial Supply Planning

For twenty years, the SCRS Global Site Solutions Summit has united clinical research sites, sponsors, and CROs to solve real industry challenges together. Join us in Orlando, Florida this October as we celebrate two decades of collaboration, education, and progress built by and for the site community. Save your seat at sitesolutionssummit.com/global.

AI-driven diversity goals are reshaping clinical supply. Better data means more sites, more cross-border shipments, and new forecasting challenges for global trials.

Coordinating CAR-T trials means managing tight timelines, cryogenic handling, staffing gaps, and chain-of-identity risks where even small missteps can delay care.

Clinical trial supply risks often surface at closeout. Planning for early termination and inventory unwind from the start helps avoid waste, delays, and costly write-offs.